‘Building a Biotech Business from Scratch’: IBioIC announces a 4-day MBA ‘More Business Acumen’ from 20-24 November in Glasgow
- Posted on 15 September, 2016
The Industrial Biotechnology Innovation Centre (IBioIC), in association with SynbiCITE, will hold a 4-Day MBA in Glasgow from 20-24 November, aiming to develop the entrepreneurship of future biotechnology leaders. The interactive course will cover key strategies required to establish, build and manage a biotechnology company with particular focus on set-up, funding and intellectual property.
The course, limited to 30 places, is aimed at budding entrepreneurs, and is ideally suited to those currently in the process of starting their own biotechnology business or intending to do so. Participants will receive valuable training from a team of experienced SynbiCITE consultants along with a registered Growth Coach, claiming over 100 years of experience in the biotechnology industry between them. There will also be a wide variety of guest speaker appearances, evening dinner presentations and unique networking opportunities with potential funders, investors and collaborators.
IBiolC, launched in 2014, is intent on bridging the gap between education and industry in the industrial biotechnology sector, envisioning the creating of a truly distinctive, world-leading innovation center for industrial biotechnology. SynbiCITE, as a pioneering Innovation and Knowledge Centre, is dedicated to promoting the adoption and use of synthetic biology by industry, and accelerating the commercialization of emerging synthetic biology and engineering biology technologies. Together they have created a stimulating and informative event, highly beneficial to all in firstname.lastname@example.org or email@example.com
Share this article:
People also read
Measurement for Recovery
Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...
SynbiTECH2020 is going virtual!
SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...